Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mutation in the
REC1
gene of Ustilago maydis is known to lead to a complex phenotype with alterations in DNA repair, recombination, mutagenesis, meiosis, and cell division. The predicted product of the
REC1
gene is a polypeptide of 522 amino acid residues with a molecular mass of 56,866 daltons, with no overall sequence homology to any other known protein. The open reading frame of the
REC1
gene placed by itself in a U. maydis expression vector was found to be sufficient to complement the rec1 mutant. Overexpression of
REC1
in Escherichia coli gave rise to the anticipated 57-kDa product together with a 3'-->5' exonuclease activity. This activity was only present in cells overexpressing
REC1
and its characteristics were distinguishable from the major bacterial nucleases, but it had certain enzymatic features in common with epsilon, the proofreading exonuclease subunit of E. coli
DNA polymerase III
holoenzyme. To facilitate isolation of the protein product from bacteria, the
REC1
gene was overexpressed from a vector that fused a hexa-histidine-leader sequence onto the amino terminus, enabling the isolation of the HisREC1 product on an immobilized metal ion affinity column. The His-
REC1
protein co-eluted with the novel exonuclease activity. Alignment of the amino acid sequence of the
REC1
gene product with the conserved proofreading exonuclease motifs of DNA polymerases indicated significant homology.
...
PMID:The REC1 gene of Ustilago maydis involved in the cellular response to DNA damage encodes an exonuclease. 827 78